Drugs / Luteolin

Trials 2 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT03288298 Nov 2017 → Sep 2018 carcinoma, tongue neoplasm Cairo University Unknown No outcome recorded
Phase 41 trial
Phase 4 NCT04853836 Nov 2020 → Oct 2021 COVID-19, anosmia University Of Perugia Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as luteolin “The studies evaluated the following interventions: systemic corticosteroids plus intranasal corticosteroid/mucolytic/decongestant and palmitoylethanolamide plus luteolin.” PMID 36062970 Sep 2022
1

NCT03288298

Known as Cyanidenon-1470 ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Digitoflavone ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Flacitran ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Luteoline ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Luteolol ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Salifazide ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Weld lake ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Known as Yama kariyasu ChEMBL registry synonym — accepted as the source's own label CHEMBL151
Modality Small molecule CHEMBL151
Route Oral “daily oral tablet that contained PEA 700 mg and Luteolin 70 mg” NCT04853836